Viewing Study NCT03568435


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2025-12-25 @ 8:14 PM
Study NCT ID: NCT03568435
Status: COMPLETED
Last Update Posted: 2022-10-20
First Post: 2018-06-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module